Global mRNA Therapeutics and Vaccines: Assessment of Technical Expertise and Relative Impact on the Field of mRNA-based Interventions

News provided by

Feb 21, 2022, 10:15 ET

DUBLIN, Feb. 21, 2022 /PRNewswire/ -- The "mRNA Therapeutics and Vaccines: Key Opinion Leaders" report has been added to ResearchAndMarkets.com's offering.

The report features the identities of some of the key opinion leaders in this domain, offering a quantitative approach to assess the relative expertise of thought leaders in this subject, along with the means for aspiring therapy developers to contact such eminent personalities.

The information has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint deck, summarizing the ongoing activity in this domain, and key insights drawn from the available data. The report features the following details:

Identities of Contemporary KOLs

An in-depth analysis of leading technical experts in the field of mRNA therapeutics and vaccines, featuring a quantitative assessment of all the available details across 30+ parameters related to individual KOLs, including the contact information of those individuals who have publicly disclosed such details

Assessment of Technical Expertise and Relative Impact on the Field of mRNA-based Interventions

An analysis of 25+ different (quantifiable) parameters, indicative of the expertise and impact created by different types of KOLs in this domain. The parameters considered in this analysis include inputs from publicly available information that describe experience, technical acumen, scientific activity, impact of contributions, strength of professional network, social media activity, and geographical location of individual KOLs

KOL Competitiveness Analysis

A competitive benchmarking and valuation analysis, taking into account all available data on 25+ parameters that highlight the relative strength (technical expertise) and impact created on the industry, by individual KOLs

KOL Profiles and Recent Activity Snapshots

Detailed profiles of top-ranking KOLs, featuring all available details, including years of experience , educational qualifications, previous / current affiliations, previous / current designations, strength of professional networks, scientific activity and contact information. In addition, this section includes brief snapshots of some of the recent contributions of the KOLs captured in the report database, who have been profiled.

Key Topics:

Identities of Contemporary KOLs
Assessment of Technical Expertise and Relative Impact on the Field of mRNA-based Interventions
KOL Competitiveness Analysis
KOL Profiles and Recent Activity Snapshots

Select Companies Mentioned:

Accent Therapeutics
Advirna
Aldevron
Allele Biotechnology
Alnylam Pharmaceuticals
AmpTech
AMS Bio
Anima Biotech
ApeXBio
Arcturus Therapeutics
Arrakis Therapeutics
ART Biosciences
AskBio
Astrazeneca
AvantiBio
Avidity Biosciences
Bharat Biotech
Biocad
Biological Mimetics
Biomay
Bioneer
BioNTech
Biosynthesis
Boehringer Ingelheim
Boston Scientific
CEA Paris
Cellema
Creative Biolabs
CureVac
Daiichi Sankyo
ElevateBio
Eli Lilly
ETH Zurich
etheRNA
Eurogentec
Garvan Research Institute
Gene Frontier Corporation
Gennova
Harvard Medical School
HDT Bio
IBM Research
Kernal Biologics
Kite Pharma
KU Leuven
KWF Kankerbestrijding
Laboratoire Drouot
Lake Pharma
Oncotherapeutics
OZ Biosciences
Pennington Biomedical Research Center
Pfizer
phaRNA
ProQR Therapeutics
Protagonist Therapeutics
PT. Dankos Farma
PTC Therapeutics
Purdue University
Quotient Clinical UK
Rabin Medical Center
Radboud University
RD Biotech
Recode Therapeutics
Regeneron
Rejuvenation Technologies
REXCELERATE
RiboPro
RNACure
Scripps Research
Seoulin Biosciences
Siranomics
Synbio Technologies
Tiba Biotech
Translate Bio
Trilink Biotechnologies
Versameb
VGXI
Ziphius Therapeutics

For more information about this report visit https://www.researchandmarkets.com/r/pi0a11

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets